β-Propiolactone UV Inactivated Clotting Factor Concentrate Is the Source of HIV-Infection of 8 Hemophilia B Patients: Confirmed

• References

• 1 Kleim JP, Bailly E, Schneweis KE, Brackmann HH, Hammerstein U, Hanfland P, van Loo B, Oldenburg J. Acute HIV infection in patients with hemophilia B treated with β-propiolyctone-UV-inactivated clotting factor. Thromb Haemost 1990; 64: 336-337
• 2 Kleim JP, Ackermann A, Brackmann HH, Gahr M, Schneweis KE. Epidemiologically closely related viruses from hemophilia B patients display high homology in two hypervariable regions of the HIV-1 env gene. AIDS Res Hum Retroviruses 1991; 7: 417-421
• 3 Cichutek K, Norley S, Linde R, Kreuz W, Gahr M, Löwer J, von Wangenheim G, Kurth R. Lack of HIV-1 V3 region sequence diversity in two haemophiliac patients infected with a putative biologic clone of HIV-1. AIDS 1991; 5: 1185-1187
• 4 Kasper P, Kaiser R, Kleim JP, Oldenburg J, Brackmann HH, Rockstroh J, Schneweis KE. Diversification of HIV-1 strains after infection from a unique source. AIDS Res Hum Retroviruses 1993; 9: 153-157
• 5 Kasper P, Kaiser R, Oldenburg J, Brackmann HH, Matz B, Schneweis KE. Parallel evolution in the V3 region of HIV type 1 after infection of hemophiliacs from a homogeneous source. AIDS Res Hum Retroviruses 1994; 10: 1669-1678